(b)(4).This follow-up report is being filled to relay additional information.The following sections were updated: b5, d1, d4, d5, e1, g1-2, g4, h2, h3, h4, h6, h10.The product was not returned and could not be analyzed.Ttherefore,, the reported event could not be fonfirmed.The review of the device manufacturing quality record indicates that (b)(4) products optipac-s 60 refobacin plus bone cement, reference 4721502084-1, lot number a703a07285 were manufactured on 24 may 2017, the device manufacturing quality record indicates that the released product met all requirements to perform as intended.No non conformity or deviation was observed which could be linked to the event described in the complaint.2 similar complaints (including the current complaint) have been recorded for optipac, reference 4721502084-1, batch a703a07285, within one year.With the available information, the exact root cause of the event could not be determined.A summary of the investigation was sent to the complainant conveying zimmer biomet conclusions.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
|